Thursday, January 29th, 2026, at 5:00 PM
Virtual Webinar
with Dr. Andrew Frank, MD, BSc (H), FRCP(C), Cognitive and Behavioural Neurologist
Who Should Attend?
Caregivers, healthcare professionals, and anyone eager to deepen their understanding of dementia.
During this engaging webinar you will learn:
✔ Stay up to date on current Alzheimer disease research, early detection, and risk reduction
✔ Understand the new anti-amyloid therapy approved by Health Canada, including eligibility and access considerations
✔ Explore diagnosis, treatment options, and care strategies for both conditions
Andrew R. Frank M.D. B.Sc.H. F.R.C.P.(C)
Dr. Andrew Frank is a cognitive and behavioural neurologist at Bruyère Memory Program at the Élisabeth Bruyère Hospital in Ottawa, Ontario.
Dr. Frank’s clinical practice is focused on the diagnosis and treatment of neurodegenerative diseases, such as dementia due to Alzheimer’s disease. His clinical interest lies in the early detection of cognitive disorders, such as Mild Cognitive Impairment (MCI). Dr. Frank’s research interest centers on investigating new pharmacologic treatments and technologies for Alzheimer’s disease.
